Consistently Modest Antidepressant Effects in Clinical Trials: the Role of Regulatory Requirements (OPEN ACCESS)

Name: Consistently Modest Antidepressant Effects in Clinical Trials: the Role of Regulatory Requirements (OPEN ACCESS)
SKU: 24340
Availability: InStock

$0.00

Want a discount? Become a member by purchasing Psychopharmacology Bulletin Subscription - Individual!

Categories: Psychopharmacology Bulletin, VOL 51 No. 3 Articles 2021 Tags: antidepressants, arif-khan, clinical-trials, effect size, Kaysee Fahl Mar, methodology, regulatory trials, walter-a-brown

Description

Description

Review Article

Consistently Modest Antidepressant Effects in Clinical Trials: the Role of Regulatory Requirements

By Arif Khan, Kaysee Fahl Mar, Walter A Brown

Consistently Modest Antidepressant Effects in Clinical Trials: the Role of Regulatory Requirements (OPEN ACCESS)

Description

Review Article

Are SNRIs More Effective than SSRIs? A Review of the Current State of the Controversy

Mechanism of Action of Antidepressants

Antidepressant Induced Apathy Responsive to Dose Reduction

Depression Rating Scales – A Doctor’s Guide

Consistently Modest Antidepressant Effects in Clinical Trials: the Role of Regulatory Requirements (OPEN ACCESS)

Description

Review Article

Related products

Are SNRIs More Effective than SSRIs? A Review of the Current State of the Controversy

Mechanism of Action of Antidepressants

Antidepressant Induced Apathy Responsive to Dose Reduction

Depression Rating Scales – A Doctor’s Guide